Stock Buybacks!™ and the Monetization of Stock-Based Compensation

Publicly traded companies are announcing record stock buyback programs and Wall Street is celebrating them as shareholder returns. But for many of the largest tech companies, these buybacks are actually offsetting the dilution from massive executive stock awards, meaning the cash isn't returning to shareholders at all. It's being transferred directly to management while the market applauds.

• The sterilization shell game. Companies award enormous amounts of stock to executives, then buy back shares to keep the share count from expanding. What gets labeled as "returning capital to shareholders" is actually monetizing the compensation these same executives just received.
• The math reveals the transfer. At Meta, stock buybacks covered only 77% of newly issued shares over a decade. At Google, it's 63%. The remaining dilution is permanent shareholder loss, while the buybacks themselves are celebrated as shareholder-friendly moves.
• Wall Street enables the narrative. Analysts treat stock-based compensation as a "non-cash" item in their earnings models, downplaying dilution. Then those same analysts trumpet the buybacks as capital returns, allowing companies to hide a direct wealth transfer within acceptable financial language.
• The scale is staggering. Meta and Google alone have transferred more than $300 billion from shareholders to employees over the past decade through this mechanism. Companies are spending 60 to 77 percent of free cash flow on this sterilization, money that could go to actual shareholder returns or business investment.
• Different companies, radically different choices. Some companies use buybacks to genuinely shrink share counts and return capital, while others use them primarily to offset executive dilution. The difference suggests this isn't inevitable, it's a choice by boards and management about whose interests matter most.